VBI VACCINES INC CDA - COM NEW (VBIV) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q3 2023

Type / Class
Equity / COM NEW
Symbol
VBIV on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$191 0
2023 Q2 58 $191 -$27,810,948 $3.28 2
2023 Q1 91,700,647 $27,831,887 -$772,744 $0.30 89
2022 Q4 94,017,080 $36,709,269 -$2,494,851 $0.39 108
2022 Q3 98,810,127 $69,958,729 -$2,721,044 $0.71 118
2022 Q2 103,061,842 $83,321,624 -$10,331,544 $0.81 123
2022 Q1 115,269,652 $191,210,992 +$6,510,077 $1.66 124
2021 Q4 111,144,305 $259,958,863 -$2,278,603 $2.34 125
2021 Q3 111,608,793 $347,247,804 -$10,075,874 $3.11 124
2021 Q2 114,696,905 $384,294,005 -$20,342,797 $3.35 133
2021 Q1 120,934,270 $376,052,674 -$1,443,631 $3.11 134
2020 Q4 121,547,498 $334,437,920 -$14,413,733 $2.75 118
2020 Q3 126,181,272 $360,911,580 +$77,629,784 $2.86 109
2020 Q2 98,440,265 $305,248,899 +$64,179,450 $3.10 98
2020 Q1 78,021,393 $74,117,453 +$1,490,699 $0.95 68
2019 Q4 75,745,909 $104,540,193 +$11,423,070 $1.38 73
2019 Q3 27,225,781 $12,851,002 +$1,269,827 $0.47 68
2019 Q2 47,171,705 $49,354,441 -$13,726,966 $1.17 54
2019 Q1 50,328,617 $91,960,801 -$1,876,355 $1.87 42
2018 Q4 51,658,475 $82,557,269 +$39,193,494 $1.60 39
2018 Q3 26,901,246 $64,706,331 -$3,375,151 $2.42 39
2018 Q2 30,895,912 $85,293,028 -$5,317,912 $2.75 46
2018 Q1 31,843,513 $111,453,434 -$62,086 $3.50 59
2017 Q4 31,835,924 $135,949,662 +$70,836,303 $4.27 60
2017 Q3 13,361,716 $51,357,877 +$2,746,601 $3.85 41
2017 Q2 12,635,980 $54,967,855 +$3,809,104 $4.35 33
2017 Q1 11,640,216 $63,905,000 +$2,844,490 $5.49 23
2016 Q4 11,122,649 $34,471,000 +$9,402,673 $3.10 20
2016 Q3 8,054,992 $27,593,000 +$12,422,505 $3.43 15
2016 Q2 4,428,897 $17,493,000 +$17,493,000 $3.95 12